サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362873

ウィメンズヘルス向け診断の市場規模、シェア、動向分析レポート：最終用途別、用途別、地域別、セグメント別予測、2023年～2030年

Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ウィメンズヘルス向け診断の市場規模、シェア、動向分析レポート：最終用途別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月04日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ウィメンズヘルス向け診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のウィメンズヘルス向け診断市場規模は2030年までに314億米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 7.3％で拡大すると予測されています。ポイントオブケア診断の採用増加、様々な慢性疾患や生活習慣病の罹患率の増加が市場成長を刺激する主な要因の一つです。このほか、さまざまな啓発プログラムの導入も、予測期間中に市場に有利に働くと予測されています。例えば、2014年には欧州委員会が「包括的がんコントロールの質向上に関する欧州ガイド」の共同活動を開始しました。

ウィメンズヘルス向け診断は、様々な団体からの資金提供の増加により、高い成長を示しています。例えば、2015年5月、Abcodia社は、卵巣がんの早期発見のためのRisk of Ovarian Cancer Algorithm（ROCA）検査を英国で発売するために、Cambridge Innovative Capital社、Scottish Equity Partners社、Albion Ventures社、UCLB社から800万米ドルの資金提供を受けた。

最終用途別に見ると、市場は病院・診断センターと家庭用に二分されます。病院・診断センターは、病院を受診する回数が多く、より確実な検出が可能であることから、市場で大きなシェアを占めています。

アジア太平洋地域の市場は、今後数年間で大きく成長する可能性が高いです。同市場の成長は、医療への投資が増加していること、国際的な機器メーカーが同地域での販売網の強化に注力していること、地域内で感染症から慢性疾患への疫学的な移行が進んでいることに起因しています。

ウィメンズヘルス向け診断市場レポート・ハイライト

  • 政府および民間団体による投資の増加と可処分所得の増加が市場を後押ししています。
  • 2017年の市場シェアはがんが最も高いです。同分野は、早期発見検査が利用可能であることや、がんに対する政府の取り組みにより、予測期間中に注目すべき成長を記録します。
  • 出生前検査は、出生前疾患の有病率の上昇、妊産婦年齢の上昇、医療支出の急増、高度診断検査の開発により、同期間中に最も急成長するセグメントと推定されます。
  • 地域別では、北米が市場を独占し、2022年には44.87％の最大収益シェアを占めました。診断センターや画像診断センターの基盤拡大、がん患者の増加、不妊検査に対する意識の高まり、ポイントオブケア検査機器の急速な普及などにより、2025年まで同市場の優位性は維持されると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ウィメンズヘルス向け診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ウィメンズヘルス向け診断市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 ウィメンズヘルス向け診断：用途の推定・動向分析

  • ウィメンズヘルス向け診断市場：重要なポイント
  • ウィメンズヘルス向け診断市場：動向と市場シェア分析、2022年と2030年
  • がん
    • がんの市場推計・予測、2018年から2030年まで
  • 感染症
    • 感染症の市場推計・予測、2018年から2030年まで
  • 骨粗鬆症
    • 骨粗鬆症の市場推計・予測、2018年から2030年まで
  • 妊娠と生殖能力
    • 妊娠と生殖能力の市場推計・予測、2018年から2030年まで
  • 出生前
    • 出生前の市場推計・予測、2018年から2030年まで

第5章 ウィメンズヘルス向け診断：最終用途の推定・動向分析

  • ウィメンズヘルス向け診断市場：重要なポイント
  • ウィメンズヘルス向け診断市場：動向と市場シェア分析、2022年と2030年
  • 病院
  • 研究室
  • 在宅ケア
  • その他

第6章 ウィメンズヘルス向け診断市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別のウィメンズヘルス向け診断市場：マーケットプレースにおける重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • F. Hoffmann-la Roche Ltd.
    • Siemens Aktiengeselischaft
    • Quest Diagnostics incorporated
    • Ge Healthcare
    • Koninklijke Philips N.V.
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Hologic, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 17 France women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 31 China women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 32 China women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 36 India women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Thailand women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa women's health diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait women's health diagnostic market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait women's health diagnostic market, by end-use, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Women's health diagnostics: market outlook
  • Fig. 9 Women's health diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Women's health diagnostics market driver impact
  • Fig. 15 Women's health diagnostics market restraint impact
  • Fig. 16 Women's health diagnostics market strategic initiatives analysis
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market: Application outlook and key takeaways
  • Fig. 19 Cancer market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 20 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 21 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 22 Pregnancy & fertility market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 23 Prenatal market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 24 Women's health diagnostics market: End-use movement analysis
  • Fig. 25 Women's health diagnostics market: End-use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 27 Laboratory market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 28 Homecare market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 30 Global women's health diagnostics market: Regional movement analysis
  • Fig. 31 Global women's health diagnostics market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Millions)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Millions)
目次
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.4 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.3% from 2023 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 44.87% in 2022. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Women's Health Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Women's Health Diagnostic Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Women's Health Diagnostic: Application Estimates & Trend Analysis

  • 4.1. Women's Health Diagnostic Market: Key Takeaways
  • 4.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cancer
    • 4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Infectious diseases
    • 4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Osteoporosis
    • 4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pregnancy & fertility
    • 4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Prenatal
    • 4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Women's Health Diagnostic: End-use Estimates & Trend Analysis

  • 5.1. Women's Health Diagnostic Market: Key Takeaways
  • 5.2. Women's Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratory
    • 5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Women's Health Diagnostic Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Women's Health Diagnostic Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-la Roche Ltd.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Aktiengeselischaft
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Quest Diagnostics incorporated
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Ge Healthcare
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Koninklijke Philips N.V.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Abbott Laboratories
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Becton, Dickinson and Company
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hologic, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives